Donate to the UCLA Integrated Substance Abuse Program
Find us on Facebook

ISAP Services

Screening, Brief Intervention, and
Referral to Treatment (SBIRT)
Training Opportunities in California

Click here for more information.

Growing Up Getting High

Marijuana is the most commonly used substance among adolescents after alcohol yet many health and allied health professionals feel unprepared to talk to their adolescent and young adult patients/clients about the effects of cannabis use; don't have the tools to identify problematic use; and are ill-informed about effective prevention strategies.

This conference, targeted to professionals in the fields of medicine, psychology, social work, nutrition, and nursing, seeks to address these knowledge and skill gaps.


Course meets the qualifications for six (6.0) hours of continuing education credits. See website for more information.

Download Flyer


2018 North American Cannabis Summit - Save the Date 2018 North American Cannabis Summit - Save the Date
North American Cannabis Summit Logo

Monitoring Cannabis Use and Population Health Outcomes in an Era of Legalization

Expect lively discussion at the 2019 North American Cannabis Summit panel presentation on the
state of public health surveillance. National and international experts will discuss the most
important considerations for cannabis surveillance to inform public health policy, such as

  • progress in cannabis monitoring and surveillance measures,
  • important populations of focus,
  • gaps and limitations in current surveillance systems,
  • examples of how data can be used in U.S. states and abroad, and
  • ways cannabis research can inform broader population-level surveillance (and vice versa).

Read more in the January 3, 2019, North American Cannabis Summit Newsletter

Opportunities and Challenges of Cannabis Equity Programs

Shaleen Title, commissioner with the Massachusetts Cannabis Control Commission, and Cat Packer, executive director of the City of Los Angeles' Department of Cannabis Regulation, will facilitate a lunch & learn session on implementing equity programs at the state and city level.

Drawing on these experts' perspectives and experience, 2019 Summit participants will leave with concrete ideas from both coasts about how they can work to advance equity programs within their own spheres of influence.

Read more in the December 27, 2018, North American Cannabis Summit Newsletter

Shaping the Future of Cannabis Policy

Over the past decades, North America has been torn apart by diametrically opposed and deeply held beliefs about cannabis. Evaluating the success of legalization efforts has been almost as divisive as legalization itself.

Read more in the December 13, 2018, North American Cannabis Summit Newsletter

Rooms are Booking Fast!

The Westin Bonaventure Hotel—home of the 2019 North American Cannabis Summit—is offering special room rates until Wednesday, December 19, 2018. After that, the official block of rooms will be released, and you may not be able to secure a room.

Don't miss the convenience and networking opportunities of staying at the hub of the 2019 Summit activity. Book your room at

Explore the 2019 Summit Program!

The 2019 Summit program is now available online. You can now explore the offerings by day, track, keyword, speaker, or session type to plan your time at the summit.

Rosalie Pacula

What role does the cannabis policy play in addressing the opioid crisis?

Watch Rosalie Pacula, co-director of the RAND Drug Policy Research Center, deliver her keynote session and find out the role cannabis policy plays in addressing the opioid crisis. Come to the 2019 North American Cannabis Summit! Register today! #NACannabisConvo #northamericancannabissummit #cannabis #marijuana #medicalmarijuana #marijuanalegalization #marijuanapolicy #populationhealth #publichealth #4HumanPotential

Register at:

Igor Grant

Marijuana as Medicine: Can We See Past the Smoke?

Medicinal use of marijuana is now legal throughout Mexico and Canada, as well as in 33 U.S. states and the District of Columbia. In June of this year, the U.S. Food and Drug Administration approved, for the first time, a drug that contains purified cannabidiol. It will be used to treat seizures associated with rare forms of epilepsy, one of many medical conditions of interest to medical cannabis researchers.

It is especially timely, then, that we announce Dr. Igor Grant's participation in the 2019 North American Cannabis Summit.

2019 North American Cannabis Summit Newsletter - November 20, 2018 (MS Word .docx file)

Gillian Schauer

2019 North American Cannabis Summit Features NIDA Expert Who Will Lead Panel on Cannabis Monitoring and Surveillance

We are pleased to announce that the 2019 North American Cannabis Summit will address the increasingly important role of monitoring and surveillance in relation to cannabis legislation and public health.

Gillian Schauer is coordinating and will participate in a keynote panel on state, national, and international efforts to collect, analyze, and interpret cannabis use data for informing public health policy. Anyone seeking to develop a robust surveillance system will not want to miss this opportunity for objective and experience-based guidance.

2019 North American Cannabis Summit Newsletter - November 13, 2018 (MS Word .docx file)

2019 NACS Press Release (.pdf file)

Cannibis Recruitment Study

Cannabis Use Disorder and Affective Management Training Study

The Cannabis Use Disorder and Affective Management Training Study is seeking individuals between the ages of 18-25 who have problems with cannabis use, experience anxiety or depression, and have trouble managing those feelings of anxiety and depression. Everyone who is eligible and decides to enroll in the study will receive a new behavioral treatment that helps young adults reduce their cannabis use by teaching them new ways of managing their feelings of anxiety and depression. If you or anyone you know is between the ages of 18-25 and would like to reduce their cannabis use while learning how to effectively manage negative feelings, please feel free to contact Nicholas Pistolesi at 310-267-5324 or at

Treating Social Anxiety Study

Social Anxiety and Alcohol Treatment Study

The Social Anxiety and Alcohol Treatment study is seeking individuals who suffer from social anxiety disorder and alcohol use problems. The study is comparing two different treatments, both which will take place at the Matrix Institute on Addiction in West Los Angeles. One treatment is their standard Intensive Outpatient Program, which meets 3 times per week for about 3 months. The other is a program that fully integrates treatment for social anxiety and alcohol problems, and is also for about 3 months, 3 times per week. Everyone who is eligible and decides to enroll will receive one of these two treatments. If you or anyone you know would be interested in participating in this study, please feel free to contact Nicholas Pistolesi by phone at 310-267-5324, or email

New Edition of Staying in Touch Manual Now Available!

Staying in Touch: A Fieldwork Manual

UCLA ISAP has collaborated with the Substance Abuse and Mental Health Services Administration (SAMHSA) and the SAMHSA Grantee Data Technical Assistance (GDTA) team to publish Staying in Touch: A Fieldwork Manual of Tracking Procedures (Third Edition).

Staying in Touch is designed to assist SAMHSA-funded grantees to stay in touch with people receiving services and to meet GPRAMA reporting requirements. The manual includes information on numerous staying-in-touch, tracking, and locating procedures from the simple and inexpensive to the complex and costly.

If you are a current SAMHSA grantee or project officer, you can access Staying in Touch.

Coming soon – downloadable PDF of Staying in Touch for everyone on the SAMHSA website. Watch this space for details!

ISAP staff riding camels in Egypt

ISAP, Egypt, and Camels…Oh My!

The 9th Kasr Al-Ainy Annual International Psychiatry Congress brought several ISAP researchers to Cairo, Egypt, in February 2016. Between the discussions about positive psychiatry, treatment strategies for adolescent substance use, psychiatric and addiction comorbidities, concepts of the cognitive behavioral therapy approach, and continuing UCLA’s training efforts with junior Egyptian psychiatrists, we had the privilege to ride camels in front of the amazing Giza pyramids.

From left to right are Rachel Castaneda and family, Jeff Annon, Christine Grella, Sherry Larkins and family, and Valerie Antonini and family. This photo does not include Karen Miotto, Al and Aaron Hasson, and Rick Rawson. All previously rode camels, apparently.

2016 ISAP Publications
2015 ISAP Publications